1st Quarter - Report
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS for AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Mar 24, 2017 | $40,000 | Replaced |
| 1st Quarter - Termination | Jul 20, 2017 | $40,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmacist Provider Status
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER RANKIN | Director of Policy and Advocacy |
Medicare/Medicaid MMM
Pharmacist provider status H.R 592/S.109
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER RANKIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.